Leerink Partnrs Has Bullish Estimate for NBIX Q1 Earnings
Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) – Stock analysts at Leerink Partnrs upped their Q1 2025 earnings per share (EPS) estimates for Neurocrine Biosciences in a report issued on Monday, February 17th. Leerink Partnrs analyst M. Goodman now expects that the company will earn $0.77 per share for the quarter, up from their previous […]
